GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kwality Pharmaceuticals Ltd

Kwality Pharma: Swanith Kapoor Appointed Independent Director

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 02 Jun 2026, 05:23 PM IST  ·  BSE ID: 67ad5942-a76b-476b-9575-85791e970cf4
View Original BSE Filing (PDF)
💡
In Simple Terms
Kwality Pharmaceuticals has a new independent director, Mr. Swanith Kapoor, while Mr. Kartik Kapur has stepped down.
🤖 AI Summary
  • Kwality Pharmaceuticals appointed Mr. Swanith Kapoor as Additional Independent Director.
  • Appointment is for a five-year term, effective June 02, 2026.
  • Mr. Swanith Kapoor meets independence criteria under Companies Act, 2013.
  • Mr. Kartik Kapur resigned as an Independent Director of the company.
🏢 How This Affects the Company
⚠️
Risk Impact
The change in independent directors does not alter the company's fundamental business operations or financial standing based on this filing.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. The appointment is subject to shareholder approval.
👤
Who Is Affected
All shareholders are affected by changes in board composition, which is overseen by the Nomination and Remuneration Committee.
🔍
Management Signal
The appointment signals management's intention to maintain board independence and comply with regulatory requirements for director composition.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Shareholder approval for Mr. Swanith Kapoor's appointment.
Future board meeting minutes for committee compositions.
Company's annual reports for director disclosures.
LOW RISK The filing reports routine management changes as per regulatory requirements, with no immediate financial implications.
💡 Investor Takeaway
Kwality Pharmaceuticals Limited has appointed Mr. Swanith Kapoor as an Additional (Non-Executive, Independent) Director for a 5-year term, replacing the resigning Independent Director, Mr. Kartik Kapur.
❓ Frequently Asked Questions
Who has been appointed as an Additional Director at Kwality Pharmaceuticals?
Mr. Swanith Kapoor has been appointed as an Additional (Non-Executive, Independent) Director at Kwality Pharmaceuticals.
What is the tenure of Mr. Swanith Kapoor's appointment?
Mr. Swanith Kapoor's appointment is for a term of 5 years, from June 02, 2026 to June 01, 2031.
Who resigned from the Board of Directors at Kwality Pharmaceuticals?
Mr. Kartik Kapur has resigned as an Independent Director of Kwality Pharmaceuticals.
Does Mr. Swanith Kapoor meet independence criteria?
Yes, the company confirms Mr. Swanith Kapoor satisfies the independence criteria prescribed under the Companies Act, 2013 and SEBI Listing Regulations.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.